Top 10 Companies in the Global Pretreatment Foam Market (2026): Market Leaders Driving Advanced Infection Control

MARKET INSIGHTS

Global pretreatment foam market size was valued at USD 1.45 billion in 2024. The market is projected to grow from USD 1.58 billion in 2025 to USD 2.87 billion by 2032, exhibiting a CAGR of 7.8% during the forecast period.

Pretreatment foams are specialized cleaning formulations used primarily in medical device reprocessing and industrial applications. These foams contain surfactants, enzymes, and other active ingredients designed to break down organic soils and biological contaminants before sterilization processes. The product category includes both enzymatic formulations for protein removal and non‑enzymatic variants for general decontamination.

The market growth is driven by increasing healthcare‑associated infection prevention measures, stricter sterilization protocols in hospitals, and rising surgical procedure volumes globally. Recent innovations in foam chemistry have improved material compatibility and cleaning efficacy, particularly for complex medical instruments. Major players like Stryker and Getinge have expanded their pretreatment foam portfolios through strategic acquisitions, with Belimed launching a new enzymatic foam concentrate in Q1 2024 specifically for robotic surgical systems.

Global Pretreatment Foam Market – View in Detailed Research Report

Top 10 Companies in the Global Pretreatment Foam Market

1. Stryker

   Headquarters: Kalamazoo, Michigan, USA
   Key Offering: Enzymatic and non‑enzymatic foams for surgical instrument reprocessing

   Stryker’s portfolio is anchored by advanced protease‑based foams that deliver rapid protein removal, allowing faster turnaround in central sterile services departments. The company’s recent acquisition of a small biotech firm has expanded its enzyme library, giving it a competitive edge in robotic surgical systems.

   Sustainability & Growth Initiatives: Stryker has invested in a closed‑loop foam production line that reduces water usage by 35% and has committed to a 30% reduction in carbon footprint by 2030.

   • Expanded enzymatic range for high‑complexity instruments
   • Partnership with major hospital networks for pilot testing
   • Launch of a digital training platform for reprocessing staff

2. Getinge Disinfection

   Headquarters: Gothenburg, Sweden
   Key Offering: High‑performance foams for endoscope and surgical tool cleaning

   Getinge’s foams are engineered to meet the latest ANSI/AAMI ST79 standards, offering up to 40% water savings versus conventional detergents. The company’s recent collaboration with a leading European hospital group has validated its low‑foaming formulations in automated endoscope reprocessing systems.

   Sustainability & Growth Initiatives: Development of a biodegradable surfactant platform and integration of recycled PET in packaging.

   • Launch of a bio‑based enzyme blend
   • Expansion into Asian emerging markets via joint venture
   • Implementation of a real‑time monitoring system for foam usage

3. Belimed

   Headquarters: Zurich, Switzerland
   Key Offering: Enzymatic foam concentrate for robotic surgical systems

   Belimed’s new concentrate, introduced in Q1 2024, delivers 99.8% protein removal and is tailored for the delicate surfaces of robotic instruments, reducing instrument wear and sterilization failures.

   Sustainability & Growth Initiatives: The company has shifted to plant‑based enzymes and is exploring micro‑encapsulation to reduce volatile organic compound emissions.

   • Strategic partnership with a leading robotic manufacturer
   • Expansion of product line to include a low‑foaming variant for AERs
   • Launch of a certification program for endoscopic reprocessing

4. Borer Chemie

   Headquarters: Zurich, Switzerland
   Key Offering: Ready‑to‑use foams for clinics and small hospitals

   Borer Chemie focuses on user‑friendly formulations that require minimal training, addressing the 32% staff‑training gap identified in industry surveys.

   Sustainability & Growth Initiatives: Investment in a new R&D hub dedicated to eco‑friendly surfactants and a zero‑waste packaging strategy.

   • Partnership with a German clinic network for pilot deployment
   • Development of a low‑foaming, high‑efficiency line for endoscope reprocessing
   • Introduction of a digital compliance tracker for sterilization workflows

5. Serchem

   Headquarters: London, UK
   Key Offering: Enzymatic foams for laboratory and research facilities

   Serchem’s formulations are optimized for laboratory glassware and research instruments, ensuring compatibility with sensitive materials and reducing chemical residue.

   Sustainability & Growth Initiatives: Development of a biodegradable foam platform and a carbon‑neutral production facility.

   • Expansion into the North American lab market
   • Launch of a multi‑enzyme blend for high‑protein labs
   • Collaboration with a leading research institute for real‑time efficacy testing

6. Kyoeisha Chemical

   Headquarters: Tokyo, Japan
   Key Offering: High‑performance foams for industrial cleaning

   Kyoeisha’s foams are tailored for large‑scale industrial applications, such as food processing and automotive manufacturing, providing robust cleaning while maintaining compliance with Japanese environmental regulations.

   Sustainability & Growth Initiatives: Integration of nanotechnology to enhance penetration and reduce chemical usage.

   • Launch of a plant‑based surfactant line
   • Partnership with a major automotive OEM for pilot studies
   • Implementation of a waste‑reduction program in production

7. Calvary Industries

   Headquarters: Atlanta, Georgia, USA
   Key Offering: Non‑enzymatic foams for cost‑sensitive markets

   Calvary offers a low‑cost, detergent‑based foam line that meets basic cleaning needs, making it attractive for clinics in emerging economies.

   Sustainability & Growth Initiatives: Development of a low‑water usage formulation and a regional distribution network to reduce transportation emissions.

   • Expansion into the South Asian market
   • Launch of a blended enzyme‑detergent for middle‑market hospitals
   • Collaboration with local NGOs to train reprocessing staff

8. MicroCare

   Headquarters: Charlotte, North Carolina, USA
   Key Offering: Ready‑to‑use foams for ambulatory surgical centers

   MicroCare’s ready‑to‑use foams are designed for quick deployment in high‑volume outpatient settings, reducing handling time and risk of contamination.

   Sustainability & Growth Initiatives: Use of renewable energy in manufacturing and a packaging recycling program.

   • Partnership with a leading ambulatory network for pilot testing
   • Launch of a rapid‑dry foam line for same‑day procedures
   • Development of a digital workflow integration tool

9. Danaher Corporation

   Headquarters: Washington, D.C., USA
   Key Offering: Integrated sterilization and pretreatment solutions

   Danaher’s portfolio combines pretreatment foams with automated sterilization systems, offering a seamless workflow that reduces manual handling and improves compliance.

   Sustainability & Growth Initiatives: Commitment to zero‑emission manufacturing and a circular economy model for packaging.

   • Launch of an AI‑driven foam usage optimizer
   • Expansion into the European market via strategic acquisitions
   • Collaboration with a global hospital consortium for standardization

10. Horizon Foam Solutions

    Headquarters: Shanghai, China
    Key Offering: Enzymatic foams for large‑scale hospital networks

    Horizon has developed a plant‑based enzyme platform that delivers high protein removal while meeting the stringent Chinese NMPA standards, positioning it well for the rapidly expanding Chinese market.

    Sustainability & Growth Initiatives: Focus on renewable raw materials and a partnership with local universities for R&D.

    • Expansion into Southeast Asian markets
    • Launch of a low‑foaming line for automated endoscope reprocessing
    • Development of a cloud‑based training portal for reprocessing staff

Download FREE Sample Report

Get Full Report

Outlook

From a base year of 2025, the market is expected to reach USD 1.58 billion, with a modest increase to USD 1.70 billion in 2026. By 2034, the forecast projects a market value of USD 4.20 billion, reflecting continued demand driven by rising surgical volumes, automation in reprocessing, and a global shift toward environmentally responsible cleaning solutions.

Future Trends

• Automation: Integration of foam dispensing into robotic and automated reprocessing systems will drive efficiency and reduce human error.
• Sustainability: Biodegradable surfactants and plant‑based enzymes will become mainstream, supported by stricter REACH‑style regulations.
• Industrial Expansion: Adoption of pretreatment foams in food processing, automotive, and electronics manufacturing will diversify the market base.
• Digitalization: AI‑powered monitoring of foam usage and real‑time compliance tracking will enhance quality control.
• Emerging Markets: India, Brazil, and Southeast Asia will account for a growing share of global demand as healthcare infrastructure expands.